feed,title,long_url,short_url
SeekingAlpha,Intellia cleared to start Phase 3 trial for gene editing drug,https://seekingalpha.com/news/4021448,
SeekingAlpha,"State Street Non-GAAP EPS of $1.93 beats by $0.10, revenue of $2.69B misses by $240M",https://seekingalpha.com/news/4021446,
